secwatch / observer
8-K filed March 25, 2026, 7:59 PM ET ticker SLXN CIK 0002022416
leadership confidence high sentiment neutral materiality 0.50

Silexion Therapeutics removes director Ilan Levin effective March 25, 2026

Silexion Therapeutics Corp

Silexion Therapeutics Corp filing history →

Source: SEC EDGAR
accession 0001178913-26-001722
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.